Autopsy report · NCT02473094

Neoadjuvant Metformin in Association to Chemoradiotherapy for Locally Advanced Rectal Cancer

Cause of deathSlow enrollment Automatic label, confidence 0.9, unverified. How labels are made.

“Slow Accrual”

The sponsor’s own words in the registry.

Life of this trial

Registered 1 month before it started.
Ran for about 7 months before it stopped.
3 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Phase 2
Sponsor: University of Campinas, Brazil
Sponsor type: University, hospital or other
Conditions: Rectal Neoplasms; Adenocarcinoma; Carcinoma
Interventions: Capecitabine; Metformin; Radiotherapy; Placebo
Participants: 3
Sites: 1
Countries: Brazil

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.